We are live on ! Find out more
YMRC

Yorktown Management & Research Company Portfolio holdings

AUM $163M
1-Year Est. Return 68.53%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+68.53%
3 Year Est. Return
+222.75%
5 Year Est. Return
+299.09%
10 Year Est. Return
+935.04%
AUM
$128M
AUM Growth
+$7.12M
Cap. Flow
-$288K
Cap. Flow %
-0.23%
Top 10 Hldgs %
15.2%
Holding
278
New
31
Increased
64
Reduced
17
Closed
36

Top Sells

Rank Stock Value
1
GNRC icon
Generac Holdings
GNRC
+$2.05M
2
FN icon
Fabrinet
FN
+$1.66M
3
MLAB icon
Mesa Laboratories
MLAB
+$1.02M
4
ETSY icon
Etsy
ETSY
+$866K
5
ULTA icon
Ulta Beauty
ULTA
+$680K

Sector Composition

Rank Sector Weight
1 Technology 25.74%
2 Healthcare 16.45%
3 Consumer Discretionary 15%
4 Industrials 13.3%
5 Financials 11.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNX icon
101
TD Synnex
SNX
$20.4B
$487K 0.38%
4,000
+1,300
+48% +$160K
KLAC icon
102
KLA
KLAC
$272B
$486K 0.38%
15,000
MPWR icon
103
Monolithic Power Systems
MPWR
$70B
$485K 0.38%
1,300
-1,700
-57% -$598K
SVA
104
DELISTED
Sinovac Biotech, Ltd
SVA
$485K 0.38%
74,893
FELE icon
105
Franklin Electric
FELE
$4.75B
$484K 0.38%
6,000
IEX icon
106
IDEX
IEX
$17.7B
$484K 0.38%
2,200
ABMD
107
DELISTED
Abiomed Inc
ABMD
$484K 0.38%
1,550
IBKR icon
108
Interactive Brokers
IBKR
$41.5B
$477K 0.37%
+29,000
New +$502K
KNX icon
109
Knight Transportation
KNX
$11.6B
$477K 0.37%
10,500
+1,500
+17% +$71.6K
BFX
110
DELISTED
BowFlex Inc.
BFX
$477K 0.37%
+28,300
New +$477K
HTHT icon
111
Huazhu Hotels Group
HTHT
$12.7B
$475K 0.37%
9,000
+4,100
+84% +$231K
IR icon
112
Ingersoll Rand
IR
$32.9B
$473K 0.37%
+9,700
New +$476K
QLYS icon
113
Qualys
QLYS
$6.47B
$473K 0.37%
4,700
+1,700
+57% +$173K
MCHP icon
114
Microchip Technology
MCHP
$43.1B
$472K 0.37%
+6,300
New +$480K
TNET icon
115
TriNet
TNET
$3.07B
$471K 0.37%
6,500
+900
+16% +$69.8K
HVT icon
116
Haverty Furniture Companies
HVT
$441M
$470K 0.37%
+11,000
New +$481K
UFPI icon
117
UFP Industries
UFPI
$5.06B
$468K 0.37%
6,300
-5,550
-47% -$438K
NBIS
118
Nebius Group N.V.
NBIS
$65.8B
$467K 0.37%
6,600
MMS icon
119
Maximus
MMS
$2.85B
$466K 0.37%
5,300
+2,000
+61% +$183K
RMBS icon
120
Rambus
RMBS
$11B
$465K 0.36%
19,600
+2,600
+15% +$52.3K
FIVE icon
121
Five Below
FIVE
$13.2B
$464K 0.36%
2,400
-2,700
-53% -$516K
ENTA icon
122
Enanta Pharmaceuticals
ENTA
$393M
$458K 0.36%
10,400
+5,900
+131% +$289K
CSGP icon
123
CoStar Group
CSGP
$12.4B
$456K 0.36%
+5,500
New +$475K
CCMP
124
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$452K 0.35%
3,000
MATX icon
125
Matsons
MATX
$6.41B
$448K 0.35%
7,000

Similar funds

Yorktown Management & Research Company's Q2 2021 Portfolio in Review

As of Q2 2021, Yorktown Management & Research Company held 278 positions worth $128M, up 5.9% from $120M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Yorktown Management & Research Company's Q2 2021 filing shows 31 new, 64 increased, 17 reduced and 36 closed positions. Its largest new stake was ScottsMiracle-Gro: 3,280 shares worth $629K. The largest sale was Generac Holdings, an estimated $2.05M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Yorktown Management & Research Company's largest Q2 2021 buy was ScottsMiracle-Gro: 3,280 shares worth $629K.
  • Yorktown Management & Research Company added most to Enanta Pharmaceuticals in Q2 2021, an estimated $289K increase.
  • Yorktown Management & Research Company's biggest Q2 2021 reduction was Generac Holdings, cutting an estimated $2.05M.
  • Yorktown Management & Research Company fully exited Fabrinet in Q2 2021, selling an estimated $1.66M.
  • Yorktown Management & Research Company's ten largest holdings make up 15% of its $128M portfolio in Q2 2021.
  • Yorktown Management & Research Company opened 31 new positions and closed 36 in Q2 2021.
  • Yorktown Management & Research Company's portfolio value rose 5.9% quarter-over-quarter to $128M.

Based on Yorktown Management & Research Company's 13F filing for Q2 2021, filed 3 Aug 2021.